{"id":904146,"date":"2025-11-03T09:36:05","date_gmt":"2025-11-03T14:36:05","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/belite-bio-to-host-webcast-on-november-10-2025-to-discuss-third-quarter-2025-financial-results\/"},"modified":"2025-11-03T09:36:05","modified_gmt":"2025-11-03T14:36:05","slug":"belite-bio-to-host-webcast-on-november-10-2025-to-discuss-third-quarter-2025-financial-results","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/belite-bio-to-host-webcast-on-november-10-2025-to-discuss-third-quarter-2025-financial-results\/","title":{"rendered":"Belite Bio to Host Webcast on November 10, 2025, to Discuss Third Quarter 2025 Financial Results"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">SAN DIEGO, Nov.  03, 2025  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ecq6jDr4G4Tvbea_VzOcIf0mw6sCRCeGHHgQdH9V2g0e2KAKjOzkytDXNMYq6IhokpRTAFzwzmG7gGoT73pX7g==\" rel=\"nofollow\" target=\"_blank\">Belite Bio<\/a>, Inc (NASDAQ: BLTE), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced that it will host a webcast on Monday, November 10, 2025, at 4:30 p.m. Eastern Time to discuss the Company\u2019s financial results and provide a business update for the third quarter ended September 30, 2025.<\/p>\n<p align=\"justify\">\n        <strong>Webcast Information<\/strong><br \/>\n        <br \/>\n        <strong>Date: <\/strong>Monday, November 10, 2025<br \/><strong>Time: <\/strong>4:30 p.m. Eastern Time (1:30 p.m. Pacific Time)<br \/><strong>Webcast Link: <\/strong><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Ss4Xlj4H6VJ6emdqetS7XymLxT_4M8thh54smc3HyJZOTr8QsHiOXMJt_HSVZjpMl3Zjq7Jpdm-t4QJmGk-GS_5HLB2puNDUtrnYSgp1seSqHP0juaBTBL3yexd_EqqKGwvszZ80wX_bqT1SVii_jlMHgHxBJyiYb2buoXGPoiU=\" rel=\"nofollow\" target=\"_blank\">https:\/\/events.q4inc.com\/attendee\/847711723<\/a><\/p>\n<p align=\"justify\">\n        <strong>Webcast Link Instructions<\/strong><br \/>\n        <br \/>You can join the live webcast by visiting the link above or the \u201cPresentations &amp; Events\u201d section of the Company\u2019s Investor Relations website at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Ss4Xlj4H6VJ6emdqetS7X395_X4luqEsZE-gzIPQq9kc13ezg0Fwx6QiPFh3hhDNQWJWCmoO4vvkXRF1NDlDR4d_yyuHzL4cFRhC2eA60WMJ4iVOs5g7LPCXPH0WIHVJf4vgx9mKJ5d1i8LfLMIwFlQnxKLqXk7upiZ4Eq1KF6xjusN_y2HPqg4sOGu9wzsS6Q-BNobrXvpsyzsu1wFiBQ==\" rel=\"nofollow\" target=\"_blank\">https:\/\/investors.belitebio.com\/presentations-events\/events<\/a>. A replay will be available for approximately 90 days after the event.<\/p>\n<p>\n        <strong>About Belite Bio<\/strong><br \/>\n        <br \/>Belite Bio is a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, such as Stargardt disease type 1 (STGD1) and Geographic Atrophy (GA) in advanced dry age-related macular degeneration (AMD), in addition to specific metabolic diseases. Belite\u2019s lead candidate, Tinlarebant, an oral therapy intended to reduce the accumulation of toxins in the eye, is currently being evaluated in a Phase 3 study (DRAGON) and a Phase 2\/3 study (DRAGON II) in adolescent STGD1 subjects and a Phase 3 study (PHOENIX) in subjects with GA. For more information, follow us on\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=95ffm0bpY_z78JFJuiivtTpf330qOG7zCnCKZ2ATq5ZQeOAAzPCH5zc9X3uf6SieV5tMKDSkSMOWEFRC1JywCw==\" rel=\"nofollow\" target=\"_blank\">X<\/a>,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=gmOrsCrDJ8jCkomLfO8wbH7j-vgv6Kz-S3vFUIUupl15U5PoQkvyviqntcJ2d6SyEpW6JaCT5m6H70xocml82BHPgA7_x7JxW1iEJk21Wk5MrSEQYG4I_Y8_Q4Hr2L3DmhQue6goxgVyQfl6UED1flE_27FcOlzM3ozjDS6brCv5G3S_6i4ph_Zj0MdcEARlxkUrgzGKeSTESqXVZSRZyL1pKOC9CTze92zBl-ao8B-3b6OyYuvVfun5AVbtSsS3qpMcNO6cdZcJy8nKNA3WjWjR9L5IVLU3RvjVCaXIy3NyVssSTuuHCdeENY9FXHnvTtQ-8f_thGjSSeEzaHndIIxfRfBqXgTB2fX-KV_VAgQSMjiBVCaBvfb8UiwT5BnQYUEg-OAk5GGpBVT6-GhxEiJpW5HkrGK3yp3bU3VVbiLzCgt7iTSRuM6Ym_aS1oCJ\" rel=\"nofollow\" target=\"_blank\">Instagram<\/a>,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=0WCpUpA_zTKbH2678N0lgp7Fcsk_dqrKCgLlxRftJyetIOoYqDVjatXlHkWzn_6rZ8A-q-NTyFjodHPLoNkZVzYokVYWh91xw4vNazZ8eRJibVg_KjKdFOe8_hV2Jhii-DH2rDWXngfrr8l1VsILw4tSPoxitxPxv0Tc3YzHkeK3EJ_-vktNQ2ILl3YN-x5zSq1kGX5TPwxyn15nB3EOECskHkl6VQbg8_w4EK5dTKKiAeduVjLLJC5xTGAr3efLuXmjD6VwnMKqQVIOGYorzallTuYdB6FVmvwG9GvK7wNIDtoWewtntgKkn_aMjULiqbKzdKW9iVPwL-LQmiA4BFjwk0mu5EBLmJ-wElWkOqbah8obtpqyuwAmZHv5QhSNZja2njNAG0Fb_7RAiodgqzHhE0p5QuXwWbxK4WEkwT6wOH7yjgMUw7-fNDLELjGa\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a>,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=cdpUEhXjlyw6uS8Q4P1Wdgi5HfjCmQ7wFMCbjMFoJGAg3swSNz3aH5pfksLs9JtS23eBU47QuUPflG-L9QVWdsKeErkt5I1FG3KR6pPLDbE=\" rel=\"nofollow\" target=\"_blank\">Facebook<\/a> or visit us at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=oAiLJmlRydxfkeWLdTiPZGmINJkr_n7eEDLX-3ltNGgyOYpFurX07GFotfcdC4vfIs06x3lWTTwb8sFhg9TnFk8zpzPD7F8Yv4qy8Y_E2bsZMh_dmsNrp6jYpyXv1fu4lKuH9MS9LmybHwIjHuAdLN2668rBm8KkR7nmCF6bsNbyAeDXUOI5_wdmkGaK10hUZKoO26UrM9gg6g_SgLdrWA4XGRhz95Hk8Dzp9MOX7XnS3Z3kTSCjeW2uZZpQfGjMPgdSQNMxukC1SvtAfmEC29roCQbGfaPvvI1ZNuO0iqeMUSQc-jI-JKmPpsNNAZbpwEmI3J1A5jv-fZOorcq3CJXZae86XYwgyrS3W2XUIDORqgsHK1x4PEqOqRzoTQA3Tg7vtLq3tAIiXtcGVme87l_LnkEzW9UKQConEgipsTLD-hwmUeA0OgoQ89plWs8cIdiDLoDoJrPZibN4XEVz4Q==\" rel=\"nofollow\" target=\"_blank\">www.belitebio.com<\/a>.<\/p>\n<p>\n        <strong>Media and Investor Relations Contact:<\/strong><br \/>\n        <br \/>Jennifer Wu <br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=2s99Z0zBSPaz94FiEo9bOCPSv5dD_VGSWZzdi3VtqHXgwIg8MJjLIZhp65eMDzYJEipS-J9D06OKBv3cOyZL6EIrFUwNkgCZM382IV9kRy8=\" rel=\"nofollow\" target=\"_blank\">ir@belitebio.com<\/a><\/p>\n<p>Julie Fallon<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=5eNfyzPQpzXn5gpnwvKuAjp6Q7nntJSlm_zLIU0LZYVk00KdtLzdzojRZYPBy63B1RfBift9xqJnzsPaoytRWX5o6QukjgUWeDWt_1YK8XjDmjpClHu7egA_ucUtAQNT\" rel=\"nofollow\" target=\"_blank\">belite@argotpartners.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2Njk2NCM3MjM5MDU2IzIyMzM3MzI=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MTQ4YjRmMDgtYzNlYy00YWQ1LWJkNzktYWNhODI3YzE3ZDhmLTEyNDUyODUtMjAyNS0xMS0wMy1lbg==\/tiny\/Belite-Bio-Inc.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SAN DIEGO, Nov. 03, 2025 (GLOBE NEWSWIRE) &#8212; Belite Bio, Inc (NASDAQ: BLTE), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced that it will host a webcast on Monday, November 10, 2025, at 4:30 p.m. Eastern Time to discuss the Company\u2019s financial results and provide a business update for the third quarter ended September 30, 2025. Webcast Information Date: Monday, November 10, 2025Time: 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time)Webcast Link: https:\/\/events.q4inc.com\/attendee\/847711723 Webcast Link Instructions You can join the live webcast by visiting the link above or the \u201cPresentations &amp; Events\u201d section of the Company\u2019s Investor Relations website at\u00a0https:\/\/investors.belitebio.com\/presentations-events\/events. A replay will be available for &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/belite-bio-to-host-webcast-on-november-10-2025-to-discuss-third-quarter-2025-financial-results\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Belite Bio to Host Webcast on November 10, 2025, to Discuss Third Quarter 2025 Financial Results&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-904146","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Belite Bio to Host Webcast on November 10, 2025, to Discuss Third Quarter 2025 Financial Results - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/belite-bio-to-host-webcast-on-november-10-2025-to-discuss-third-quarter-2025-financial-results\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Belite Bio to Host Webcast on November 10, 2025, to Discuss Third Quarter 2025 Financial Results - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SAN DIEGO, Nov. 03, 2025 (GLOBE NEWSWIRE) &#8212; Belite Bio, Inc (NASDAQ: BLTE), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced that it will host a webcast on Monday, November 10, 2025, at 4:30 p.m. Eastern Time to discuss the Company\u2019s financial results and provide a business update for the third quarter ended September 30, 2025. Webcast Information Date: Monday, November 10, 2025Time: 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time)Webcast Link: https:\/\/events.q4inc.com\/attendee\/847711723 Webcast Link Instructions You can join the live webcast by visiting the link above or the \u201cPresentations &amp; Events\u201d section of the Company\u2019s Investor Relations website at\u00a0https:\/\/investors.belitebio.com\/presentations-events\/events. A replay will be available for &hellip; Continue reading &quot;Belite Bio to Host Webcast on November 10, 2025, to Discuss Third Quarter 2025 Financial Results&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/belite-bio-to-host-webcast-on-november-10-2025-to-discuss-third-quarter-2025-financial-results\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-03T14:36:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2Njk2NCM3MjM5MDU2IzIyMzM3MzI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/belite-bio-to-host-webcast-on-november-10-2025-to-discuss-third-quarter-2025-financial-results\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/belite-bio-to-host-webcast-on-november-10-2025-to-discuss-third-quarter-2025-financial-results\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Belite Bio to Host Webcast on November 10, 2025, to Discuss Third Quarter 2025 Financial Results\",\"datePublished\":\"2025-11-03T14:36:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/belite-bio-to-host-webcast-on-november-10-2025-to-discuss-third-quarter-2025-financial-results\\\/\"},\"wordCount\":272,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/belite-bio-to-host-webcast-on-november-10-2025-to-discuss-third-quarter-2025-financial-results\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU2Njk2NCM3MjM5MDU2IzIyMzM3MzI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/belite-bio-to-host-webcast-on-november-10-2025-to-discuss-third-quarter-2025-financial-results\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/belite-bio-to-host-webcast-on-november-10-2025-to-discuss-third-quarter-2025-financial-results\\\/\",\"name\":\"Belite Bio to Host Webcast on November 10, 2025, to Discuss Third Quarter 2025 Financial Results - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/belite-bio-to-host-webcast-on-november-10-2025-to-discuss-third-quarter-2025-financial-results\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/belite-bio-to-host-webcast-on-november-10-2025-to-discuss-third-quarter-2025-financial-results\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU2Njk2NCM3MjM5MDU2IzIyMzM3MzI=\",\"datePublished\":\"2025-11-03T14:36:05+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/belite-bio-to-host-webcast-on-november-10-2025-to-discuss-third-quarter-2025-financial-results\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/belite-bio-to-host-webcast-on-november-10-2025-to-discuss-third-quarter-2025-financial-results\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/belite-bio-to-host-webcast-on-november-10-2025-to-discuss-third-quarter-2025-financial-results\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU2Njk2NCM3MjM5MDU2IzIyMzM3MzI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU2Njk2NCM3MjM5MDU2IzIyMzM3MzI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/belite-bio-to-host-webcast-on-november-10-2025-to-discuss-third-quarter-2025-financial-results\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Belite Bio to Host Webcast on November 10, 2025, to Discuss Third Quarter 2025 Financial Results\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Belite Bio to Host Webcast on November 10, 2025, to Discuss Third Quarter 2025 Financial Results - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/belite-bio-to-host-webcast-on-november-10-2025-to-discuss-third-quarter-2025-financial-results\/","og_locale":"en_US","og_type":"article","og_title":"Belite Bio to Host Webcast on November 10, 2025, to Discuss Third Quarter 2025 Financial Results - Market Newsdesk","og_description":"SAN DIEGO, Nov. 03, 2025 (GLOBE NEWSWIRE) &#8212; Belite Bio, Inc (NASDAQ: BLTE), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced that it will host a webcast on Monday, November 10, 2025, at 4:30 p.m. Eastern Time to discuss the Company\u2019s financial results and provide a business update for the third quarter ended September 30, 2025. Webcast Information Date: Monday, November 10, 2025Time: 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time)Webcast Link: https:\/\/events.q4inc.com\/attendee\/847711723 Webcast Link Instructions You can join the live webcast by visiting the link above or the \u201cPresentations &amp; Events\u201d section of the Company\u2019s Investor Relations website at\u00a0https:\/\/investors.belitebio.com\/presentations-events\/events. A replay will be available for &hellip; Continue reading \"Belite Bio to Host Webcast on November 10, 2025, to Discuss Third Quarter 2025 Financial Results\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/belite-bio-to-host-webcast-on-november-10-2025-to-discuss-third-quarter-2025-financial-results\/","og_site_name":"Market Newsdesk","article_published_time":"2025-11-03T14:36:05+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2Njk2NCM3MjM5MDU2IzIyMzM3MzI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/belite-bio-to-host-webcast-on-november-10-2025-to-discuss-third-quarter-2025-financial-results\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/belite-bio-to-host-webcast-on-november-10-2025-to-discuss-third-quarter-2025-financial-results\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Belite Bio to Host Webcast on November 10, 2025, to Discuss Third Quarter 2025 Financial Results","datePublished":"2025-11-03T14:36:05+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/belite-bio-to-host-webcast-on-november-10-2025-to-discuss-third-quarter-2025-financial-results\/"},"wordCount":272,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/belite-bio-to-host-webcast-on-november-10-2025-to-discuss-third-quarter-2025-financial-results\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2Njk2NCM3MjM5MDU2IzIyMzM3MzI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/belite-bio-to-host-webcast-on-november-10-2025-to-discuss-third-quarter-2025-financial-results\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/belite-bio-to-host-webcast-on-november-10-2025-to-discuss-third-quarter-2025-financial-results\/","name":"Belite Bio to Host Webcast on November 10, 2025, to Discuss Third Quarter 2025 Financial Results - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/belite-bio-to-host-webcast-on-november-10-2025-to-discuss-third-quarter-2025-financial-results\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/belite-bio-to-host-webcast-on-november-10-2025-to-discuss-third-quarter-2025-financial-results\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2Njk2NCM3MjM5MDU2IzIyMzM3MzI=","datePublished":"2025-11-03T14:36:05+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/belite-bio-to-host-webcast-on-november-10-2025-to-discuss-third-quarter-2025-financial-results\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/belite-bio-to-host-webcast-on-november-10-2025-to-discuss-third-quarter-2025-financial-results\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/belite-bio-to-host-webcast-on-november-10-2025-to-discuss-third-quarter-2025-financial-results\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2Njk2NCM3MjM5MDU2IzIyMzM3MzI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2Njk2NCM3MjM5MDU2IzIyMzM3MzI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/belite-bio-to-host-webcast-on-november-10-2025-to-discuss-third-quarter-2025-financial-results\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Belite Bio to Host Webcast on November 10, 2025, to Discuss Third Quarter 2025 Financial Results"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/904146","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=904146"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/904146\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=904146"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=904146"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=904146"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}